Cellebrite director granted 15,190 RSUs

A Cellebrite DI Ltd. director received a new RSU equity award that will vest in 2027 and increase his directly held Ordinary Shares.

Rhea-AI Filing Summary

Cellebrite DI Ltd. (symbol: CLBT) is the issuer of record for a Form 4 filing submitted to the SEC. Van Buren Brandon reported acquisition or exercise transactions in this Form 4 filing.

Cellebrite DI Ltd. (CLBT) reported that director Brandon Van Buren received an equity compensation award in the form of 15,190 restricted share units (RSUs) on September 17, 2026. The RSUs will vest on September 17, 2027, with each RSU delivering one Ordinary Share upon settlement, increasing his directly held Ordinary Shares to 50,744.

Insider Trade Summary

Grant/Award: 15,190 shares

Grant/Award 1 txn

Insider Van Buren Brandon

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary shares, par value NIS 0.00001 F1	15,190	$0.00	$0.00

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 50,744 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Key Figures

RSUs granted: 15,190 units Shares following transaction: 50,744 shares Grant date: September 17, 2026 +1 more

4 metrics

RSUs granted 15,190 units Equity award to director on September 17, 2026

Shares following transaction 50,744 shares Director’s directly held Ordinary Shares after RSU award

Grant date September 17, 2026 Date of RSU grant to director

Vesting date September 17, 2027 RSUs vest in full on this date

Key Terms

restricted share units ("RSUs"), contingent right, Ordinary Share

3 terms

restricted share units ("RSUs") financial

"Represents an award of restricted share units ("RSUs") that will vest"

contingent right financial

"Each RSU represents a contingent right to receive one Ordinary Share"

Ordinary Share financial

"receive one Ordinary Share of the Issuer upon settlement"

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CLBT disclose for Brandon Van Buren?

Cellebrite DI Ltd. disclosed that director Brandon Van Buren received an award of 15,190 RSUs on September 17, 2026. The RSUs will vest on September 17, 2027, with each RSU settling into one Ordinary Share of Cellebrite.

How many CLBT shares does Brandon Van Buren hold after this Form 4 transaction?

After the reported RSU grant, Brandon Van Buren directly holds 50,744 Ordinary Shares of Cellebrite DI Ltd., as stated in the Form 4 following the award of 15,190 restricted share units.

When do the newly granted CLBT RSUs to Brandon Van Buren vest?

The newly granted RSUs to Brandon Van Buren will vest on September 17, 2027. Upon settlement at vesting, each RSU represents a contingent right to receive one Ordinary Share of Cellebrite DI Ltd.

What type of security was granted to the CLBT director in this filing?

The filing reports an award of restricted share units (RSUs). Each RSU is a contingent right that, upon settlement at vesting, delivers one Ordinary Share of Cellebrite DI Ltd. to the reporting person.

Was the CLBT insider RSU award a purchase for cash?

No. The Form 4 describes the transaction as a grant or award of 15,190 RSUs at a reported price of $0.00 per share, indicating it is an equity compensation award rather than a cash purchase in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 08:53 AM Accepted by SEC EDGAR 09/17/2026 - 08:53 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Van Buren Brandon

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	09/17/2026		A		15,190(1)	A	$0	50,744	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Remarks:

	/s/ Brandon Van Buren	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)